查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391981

免疫细胞工程市场：按细胞类型、副产品、按适应症、按应用、按最终用户、按地区

Immune Cell Engineering Market, By Cell Type, By Product, By Disease Indication, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

免疫细胞工程的全球市场规模预计将从 2023 年的 28.2 亿美元增至 2030 年的 116.6 亿美元，预测期内复合年增长率为 22.5%。

报告范围 报告详情
基准年 2022年 2023年市场规模 28.2亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 22.50% 2030年市场规模预测 116.6亿美元
图 1. 2023 年免疫细胞技术的全球市场占有率(%)（按地区）
免疫细胞工程市场-IMG1

免疫细胞工程是近年来受到广泛关注的领域，因为它有可能彻底改变包括癌症在内的各种疾病的治疗。免疫细胞工程涉及对免疫细胞的操纵和修饰，以提高其靶向和破坏癌细胞和其他病原体的能力。这个新领域结合了免疫学、分子生物学和基因工程的原理来开发创新的治疗方法。

免疫系统在识别和消除体内外来入侵者和异常细胞方面发挥着重要作用。然而，针对某些疾病的免疫反应可能不足或无效。透过对免疫细胞进行基因改造，科学家可以提高其识别和攻击特定目标（例如癌细胞）的能力。

市场动态：

免疫细胞工程市场由几个关键因素驱动。首先，癌症、自体自体免疫疾病、感染疾病等多种疾病的盛行率不断增加。这些疾病的常规治疗方法通常有局限性，因此需要创新的治疗方法。

其次，基因编辑技术的进步显着提高了免疫细胞工程的效率和精确度。 CRISPR/Cas9 等基因编辑工具使修改免疫细胞变得更加容易，从而增加了其治疗潜力。这些技术创新预计将推动免疫细胞工程市场的成长。

然而，也存在一些需要解决的挑战和阻碍因素。主要挑战之一是免疫细胞工程治疗的高成本。这些治疗方法的开发和製造流程非常复杂，需要专门的设施和专业知识。这限制了这些治疗方法的可用性，特别是在新兴国家。

例如，2022年12月，製药公司吉利德科学公司宣布收购临床阶段生物技术公司Tmunity Therapeutics Inc.。透过此次收购，吉利德科学将获得临床前和临床项目，包括一个「装甲」CAR T技术平台，该平台有潜力应用于多种CAR T细胞，以增强抗肿瘤活性，并有助于加强产品製造流程。

本研究的主要特点

  • 该报告详细分析了全球免疫细胞工程市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球免疫细胞技术市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、经营团队升级、市场扩张和行销策略做出资讯的决策。
  • 全球免疫细胞工程市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球免疫细胞工程市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章免疫细胞工程市场-冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章免疫细胞工程市场，依细胞类型，2023-2030

  • 介绍
  • T细胞
  • 自然杀手细胞
  • 树突状细胞
  • 癌细胞
  • 干细胞
  • 其他的

第六章免疫细胞工程市场（依产品），2023-2030

  • 介绍
  • 消耗品
  • 装置
  • 软体

第七章免疫细胞工程市场，依疾病适应症，2023-2030

  • 介绍
  • 心血管疾病
  • 呼吸系统疾病
  • 感染疾病
  • 癌症
  • 神经系统疾病
  • 其他的

第八章免疫细胞工程市场，依应用分类，2023-2030

  • 介绍
  • 研究用途
  • 细胞疗法和再生医学
  • 其他的

第 9 章免疫细胞工程市场，按最终用户划分，2023-2030 年

  • 介绍
  • 製药和生物技术公司
  • 医院和诊所
  • 学术研究所
  • 细胞库
  • 其他的

第10章免疫细胞工程市场，依地区，2023-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争形势

  • Thermo Fisher Scientific,Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza
  • Miltenyi Biotec
  • Takara Bio Inc.
  • Sartoroius CellGenix GmbH
  • FUJIFILM Irvine Scientific
  • Agilent Technologies,Inc.
  • Bio-Techne
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Charles River Laboratories
  • Creative Bioarray
  • Sartorius AG
  • Novogene Co, Ltd.
  • AGC Biologics
  • Catalent, Inc
  • WuXi AppTec
  • Discovery Life Sciences

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6350

The global immune cell engineering market size is expected to reach US$ 11.66 Bn by 2030, from US$ 2.82 Bn in 2023, at a CAGR of 22.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.82 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 22.50% 2030 Value Projection: US$ 11.66 Bn
Figure 1. Global Immune Cell Engineering Market Share (%), By Region, 2023
Immune Cell Engineering Market - IMG1

Immune cell engineering is a field that has gained significant attention in recent years due to its potential to revolutionize the treatment of various diseases, including cancer. It involves the manipulation and modification of immune cells to enhance their ability to target and destroy cancer cells or other pathogens. This emerging field combines principles of immunology, molecular biology, and genetic engineering to develop innovative therapies.

The immune system plays a critical role in recognizing and eliminating foreign invaders or abnormal cells in the body. However, in some cases, the immune response may be insufficient or ineffective against certain diseases. By genetically modifying immune cells, scientists can enhance their ability to recognize and attack specific targets, such as cancer cells.

Market Dynamics:

The immune cell engineering market is driven by several key factors. Firstly, there is a growing prevalence of various diseases, including cancer, autoimmune disorders, and infectious diseases. As traditional treatment options for these diseases often have limitations, there is a need for innovative therapeutic approaches.

Secondly, advancements in gene-editing technologies have significantly improved the efficiency and precision of immune cell engineering. Gene-editing tools such as CRISPR/Cas9 have made it easier to modify immune cells and enhance their therapeutic potential. These technological innovations are expected to drive the growth of the immune cell engineering market.

However, there are also several challenges and restraints that need to be addressed. One of the main challenges is the high cost associated with immune cell engineering therapies. The development and manufacturing processes for these therapies are complex and require specialized facilities and expertise. This has limited the accessibility of these therapies, particularly in developing countries.

For instance, in December 2022, Gilead Sciences, Inc., a pharmaceutical company, announced the acquisition of Tmunity Therapeutics Inc., a clinical-stage biotechnology company. The acquisition provided Gilead Sciences, Inc. with preclinical and clinical programs, including an "armored" CAR T technology platform that has the potential to be applied to a variety of CAR T cells to enhance anti-tumor activity, and helps to enhance manufacturing processes for of CAR T cells product.

Key features of the study:

  • This report provides in-depth analysis of the global immune cell engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global immune cell engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza, Miltenyi Biotec, Takara Bio Inc., Sartoroius CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Co, Ltd., AGC Biologics, Catalent, Inc., WuXi AppTec, Discovery Life Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global immune cell engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immune cell engineering market

Detailed Segmentation:

  • Global Immune Cell Engineering Market, By Cell Type
    • T Cells
    • NK Cells
    • Dendritic Cells
    • Tumor Cells
    • Stem Cells
    • Others
  • Global Immune Cell Engineering Market, By Product
    • Consumables
    • Instruments
    • Software
  • Global Immune Cell Engineering Market, By Disease Indication
    • Cardiovascular Diseases
    • Respiratory Diseases
    • Infectious Diseases
    • Cancer
    • Neurological Diseases
    • Others
  • Global Immune Cell Engineering Market, By Application
    • Research Applications
    • Cell Therapy & Regenerative Medicine
    • Others
  • Global Immune Cell Engineering Market, By End User
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinics
    • Academic & Research Institutes
    • Cell Banks
    • Others
  • Global Immune Cell Engineering Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Top companies in Immune Cell Engineering Market:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Lonza
    • Miltenyi Biotec
    • Takara Bio Inc.
    • Sartoroius CellGenix GmbH
    • FUJIFILM Irvine Scientific
    • Agilent Technologies, Inc.
    • Bio-Techne
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Charles River Laboratories
    • Creative Bioarray
    • Sartorius AG
    • Novogene Co, Ltd.
    • AGC Biologics
    • Catalent, Inc
    • WuXi AppTec
    • Discovery Life Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Immune Cell Engineering Market, By Cell Type
    • Market Immune Cell Engineering Market, By Product
    • Market Immune Cell Engineering Market, By Disease Indication
    • Market Immune Cell Engineering Market, By Application
    • Market Immune Cell Engineering Market, By End User
    • Market Immune Cell Engineering Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Immune Cell Engineering Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Immune Cell Engineering Market , By Cell Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • T Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • NK Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Dendritic Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Tumor Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Immune Cell Engineering Market , By Product, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Immune Cell Engineering Market , By Disease Indication, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neurological Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Immune Cell Engineering Market , By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Research Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cell Therapy & Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Immune Cell Engineering Market , By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cell Banks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Immune Cell Engineering Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U..K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

  • Thermo Fisher Scientific,Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Danaher Corporation
  • Lonza
  • Miltenyi Biotec
  • Takara Bio Inc.
  • Sartoroius CellGenix GmbH
  • FUJIFILM Irvine Scientific
  • Agilent Technologies,Inc.
  • Bio-Techne
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Charles River Laboratories
  • Creative Bioarray
  • Sartorius AG
  • Novogene Co, Ltd.
  • AGC Biologics
  • Catalent, Inc
  • WuXi AppTec
  • Discovery Life Sciences
  • Analyst Views

12. Section

  • Research Methodology
  • About us